Evidence map›Paper›PMID 39378954›Full record

ArticleJournal of substance use and addiction treatment2025

Was receipt of any specialty alcohol treatment during the pandemic effective at reducing drinking for patients with or at risk of AUD?

Andrea H Kline-Simon, Vanessa A Palzes, Felicia W Chi, Derek D Satre, Constance Weisner, Stacy A Sterling

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea H Kline-SimonDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America. Electronic address: andrea.h.kline-simon@kp.org.
Vanessa A PalzesDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America.
Felicia W ChiDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America.
Derek D SatreDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, 675 18(th) Street, San Francisco, CA 94107, United States of America.
Constance WeisnerDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, 675 18(th) Street, San Francisco, CA 94107, United States of America.
Stacy A SterlingDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, 675 18(th) Street, San Francisco, CA 94107, United States of America; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, United States of America.

Funding

Mentoring alcohol use intervention research in HIV health care settingsK24AA025703 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre · 2018 to 2026
$1.8M
KAISER PERMANENTE OF NORTHERN CALIFORNIA (KPNC) ALCOHOL REGISTRY75N94021C00003 · NICHD · KAISER FOUNDATION RESEARCH INSTITUTE · PI WEISNER, DR.PH., MSW, CONSTANCE · 2022 to 2025
$737k
NIAAA NIH HHS K24 AA025703NICHD NIH HHS 75N94021C00003
6 · The paper itself

Abstract

introductionThe COVID-19 pandemic changed the way healthcare providers delivered most health services, including treatment for alcohol use disorder (AUD). Specialty alcohol treatment remained available through the pandemic, and within some systems treatment use increased likely due to telehealth availability. However, the field knows little about the relationship between the pandemic's expanded access to specialty alcohol treatment and alcohol use outcomes.

methodsThe sample included 14,712 patients from Kaiser Permanente Northern California who screened positive for unhealthy alcohol use in primary care and had an AUD diagnosis or risked developing an AUD by reporting 5 or more heavy drinking days in a 3-month period between 1/1/2019 and 2/29/2020 (pre-pandemic). The study examined the receipt of any specialty alcohol treatment (including at least one outpatient, inpatient, or telehealth specialty treatment encounter, or pharmacotherapy prescription) from 3/1/2020 (pandemic start) to either the first completed follow-up alcohol screening or 6/20/2022 (study period end). The outcomes of alcohol use included changes in heavy drinking days, drinks per week, drinking days per week, and drinks per drinking day between the pre- and post-pandemic periods.

resultsOn average patients significantly decreased alcohol use across all four alcohol use measures examined, regardless of whether they received treatment. However, those who received any treatment compared to those who did not had greater reductions in alcohol use, with an additional decrease of -3.55 heavy drinking days (95 % CI = -5.93, -1.17), -3.80 drinks per week (95 % CI = -5.18, -2.42), -0.72 drinks per drinking day (95 % CI = -1.14, -0.30), and - 1.01 drinking days per week (95 % CI = -1.30, -0.72). Treatment effects were greatest among patients who exceeded both daily and weekly limits pre-pandemic, with an additional decrease of -10.75 heavy drinking days (95 % CI = -15.28, -6.21), -12.83 drinks per week (95 % CI = -16.31, -9.35), -1.67 drinks per drinking day (95 % CI = -2.19, -1.14), and -2.02 drinking days per week (95 % CI = -2.41, -1.63).

conclusionsOn average, patients decreased alcohol use during the onset of the pandemic, however, those who had any specialty alcohol treatment had significantly greater decreases, suggesting that the hybrid in-person and telehealth treatment approach was effective during the pandemic.

Indexed as

Alcohol DrinkingAlcoholismCOVID-19TelemedicineAdultCaliforniaFemaleHumansMaleMiddle AgedPrimary Health CareAlcohol useAUDDrinkingPandemicSpecialty alcohol treatment

Identifiers

PMID39378954
PMCPMC11624079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.